NCT06288399Completed
Prevalence and Economic Burden of Obesity-related Comorbidities in the Gulf Region: A Retrospective, Observational Study
Source: ClinicalTrials.gov · Last updated 15 Oct 2025
Brief summary (registry, in English)
The aim of this study is to assess the annual prevalence of ORCs among adult people with obesity in the real-world clinical setting across the Gulf region. In addition, the study will describe the annual HCRU and associated costs of obesity and ORCs, describe the demographics and clinical characteristics of adult people with obesity, as well as estimate the annual incidence and point prevalence of the ORCs among adult people with obesity.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1316 (actual)
- First submitted
- 23 Feb 2024
- Start date
- 21 Dec 2023
- Primary completion date
- 30 Sept 2024
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Obesity
- NCT number
- NCT06288399
What you commit to
- Study type: Observational
- Participants enrolled: 1316
- From 21 Dec 2023 to the primary completion date, 30 Sept 2024
- 7 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous participation in this study. Participation is defined as having collected data of the participants in this study already.
- Participants who underwent bariatric surgery within 18 months prior to the index date
Other illness
- Conditions associated with unintentional weight change
Other
- Participation in an interventional trial during the 12-month observation period
- Participants with non-ambulatory disability diagnosis
Who the study is looking for
- Local national (male or female) of Arab ethnicity, age above or equal to 18 years at index date
- Primary or secondary diagnosis of obesity (BMI above or equal to 30 kg/m2) at index date
- Minimum of 1 visit with BMI recorded between months 1 and 6 following index date, and minimum of 1 visit with BMI recorded between months 7 and 12 following index date.
- There should be a minimum time gap of 3 months between the BMI records and the BMI must be above or equal 30 kg/m2 at each visit. If there are multiple visits during the 12-month observation period, then a mean BMI above or equal 30 kg/m2 must be maintained during the observation period.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Farwaniya Hospital Coordinator of this site? Confirm its status | Farwaniya | Kuwait | Unknown status |
| Al-Adan Hospital Coordinator of this site? Confirm its status | Hadiya | Kuwait | Unknown status |
| Al-Amiri Hospital Coordinator of this site? Confirm its status | Kuwait City | Kuwait | Unknown status |
| National Diabetes and Endocrine Center Coordinator of this site? Confirm its status | Muscat | Oman | Unknown status |
| Samail Polyclinic Coordinator of this site? Confirm its status | Samail | Oman | Unknown status |
| Hamad General Hospital Coordinator of this site? Confirm its status | Doha | Qatar | Unknown status |
| PHCC Coordinator of this site? Confirm its status | Doha | Qatar | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.